Despite improved antimicrobial therapy and preventative practices, hospital acquired and ventilator associated pneumonia remain important causes of morbidity and mortality

HAP & VAP continues to challenge intensivists, microbiologists, ID physicians and laboratory staff alike, from initial diagnosis to choice of effective treatment regimens.